Application of precision medicine to cervical cancer prevention
Friday, June 17, 2016
Scientific Session
•
SS 06
•
9:45 AM
>
11:00 AM
•
Application of precision medicine to cervical cancer prevention
•
Mozart 4-5
Scientific Session
•
SS 06-02
•
Urine based HPV screening in low resource settings
>
J.
Jennifer
Smith
•
SS 06-04
•
Risk-based screening and triage: The example of p16/Ki-67 dual stain
See abstract
>
N.
Nicolas
Wentzensen
•
SS 06-06
•
Optimal methods for cervical cancer screening among HIV positive women
See abstract
>
T.
Timothy
Wilkin
•
SS 06-07
•
Conclusion: Applying Precision Medicine Initiative to screen and treat HPV associated cancers
>
A.
Anna
Giuliano
•
SS 06-01
•
HPV testing as a primary screen in the era of HPV vaccination. A numbers game
See abstract
>
E.
Eduardo
Franco
•
SS 06-03
•
Host and HPV methylation – adjunctive biomarkers that improve CIN3 diagnosis specificity
See abstract
>
A.
Attila
Lorincz
•
SS 06-05
•
Application of precision medicine to cervical cancer prevention: Will menopausal women become the highest risk population?
See abstract
>
P.
Peter
Sasieni
|